← Back to guidelines
Cardiology33 papers

Glossopharyngeal neuralgia

Last edited: 4/14/2026

Overview

Glossopharyngeal neuralgia (GPN) is characterized by severe, episodic pain originating from the glossopharyngeal nerve, typically affecting the throat, tonsil, and possibly radiating to the ear. It can be idiopathic or secondary to conditions like chronic tonsillitis or mass effects 13.

Diagnosis

  • Clinical Presentation: Severe, paroxysmal pain in the throat, tonsillar region, and base of the tongue, often triggered by swallowing 12.
  • Imaging: MRI or CT scans may help rule out secondary causes such as tumors or inflammation 1.
  • Electrophysiological Studies: Rarely needed but can confirm neuralgia 3.
  • Differential Diagnosis: Exclude other causes like trigeminal neuralgia, migraines, and cardiovascular issues 4.
  • Management

  • First-Line Treatments:
  • - Antibiotics: For secondary GPN due to chronic tonsillitis 1. - Percutaneous Nerve Blocks: Such as glossopharyngeal nerve block, neurolysis, or pulsed radiofrequency neuromodulation 1.
  • Adjunctive Treatments:
  • - Ketamine: Oral dose of 60 mg administered six times daily for NMDA receptor blockade; effective in reducing pain intensity 2. - Thermocoagulation: Percutaneous controlled thermocoagulation of Andersch's ganglion as a surgical intervention 3.

    Special Populations

  • Comorbidities: Patients with chronic tonsillitis may require antibiotic therapy alongside nerve interventions 1.
  • No specific data: Limited information on GPN management in pregnancy, pediatrics, or elderly populations from the provided abstracts 1234.
  • Key Recommendations

  • Consider secondary causes like chronic tonsillitis when idiopathic GPN symptoms worsen or new triggers emerge (Evidence: Moderate 1).
  • Evaluate and treat with antibiotics if secondary GPN due to tonsillitis is identified (Evidence: Moderate 1).
  • Utilize percutaneous nerve interventions such as blocks or thermocoagulation for refractory cases (Evidence: Weak 13).
  • Consider ketamine for pain relief in patients with persistent symptoms unresponsive to other treatments (Evidence: Moderate 2).
  • In cases with neurological symptoms like seizures or syncope, consider intracranial procedures targeting the glossopharyngeal nerve (Evidence: Weak 4).
  • References

    1 Kim E, Do W, Jung YH, Lee J, Baik J. Gradual aggravation of idiopathic glossopharyngeal neuralgia due to chronic tonsillitis: A case report. Medicine 2019. link 2 Eide PK, Stubhaug A. Relief of glossopharyngeal neuralgia by ketamine-induced N-methyl-aspartate receptor blockade. Neurosurgery 1997. link 3 Houdek M, Burval S. Thermocoagulation of Andersch's ganglion (ganglion inferius n. glossopharyngei) in the treatment of glossopharyngeal neuralgia. Acta Universitatis Palackianae Olomucensis Facultatis Medicae 1990. link 4 St John JN. Glossopharyngeal neuralgia associated with syncope and seizures. Neurosurgery 1982. link

    Original source

    1. [1]
    2. [2]
    3. [3]
      Thermocoagulation of Andersch's ganglion (ganglion inferius n. glossopharyngei) in the treatment of glossopharyngeal neuralgia.Houdek M, Burval S Acta Universitatis Palackianae Olomucensis Facultatis Medicae (1990)
    4. [4]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG